Emily M Xu

Biological Scientist III

Department: MD-PEDS-CELL – MOLEC THERP DIV

Business Phone: (352) 273-9342

Business Email: emxu@ufl.edu

Publications

Academic Articles

Interrogating the dependency of AAV capsids on AAVR for retinal transduction.
2026

Journal

Molecular therapy. Advances.

Volume/Issue

34(1)

[DOI]

10.1016/j.omta.2026.201677.

[PMID]

42137287.

PubMed Publisher’s Site
Development of an AAV-based gene therapy for the ocular phenotype of Friedreich’s ataxia.
2026

Journal

Molecular therapy : the journal of the American Society of Gene Therapy.

Volume/Issue

34(2):771-788

[DOI]

10.1016/j.ymthe.2025.10.048.

[PMID]

41137390.

PubMed Publisher’s Site
Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6.
2023

Journal

Molecular therapy. Methods & clinical development.

Volume/Issue

30:48-64

[DOI]

10.1016/j.omtm.2023.05.020.

[PMID]

37361352.

5 citations PubMed Publisher’s Site

Contact Details

Phones:

Business:: (352) 273-9342

Emails:

Business:: emxu@ufl.edu

Addresses:

Business Mailing:: 1699 SW 16TH AVE BLDG A
GAINESVILLE FL 32608